Mimikai Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$4M
- Investors
-
12
Mimikai General Information
Description
Producer of a plant-powered insect repellent designed to provide effective protection in a gentle, clean-ingredient format. The company offers botanical formulas, refined fragrances, and skin-friendly compositions, enabling outdoor consumers a safer and more pleasant repellent experience.
Contact Information
Website
www.mimikai.comCorporate Office
- 3519 North East 15th Avenue
- Suite 292
- Portland, OR 97212
- United States
Corporate Office
- 3519 North East 15th Avenue
- Suite 292
- Portland, OR 97212
- United States
Mimikai Timeline
Mimikai Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | 26-Nov-2024 | $4M | Completed | Generating Revenue | ||
| 3. Seed Round | 16-Mar-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 25-Aug-2021 | $545K | $1.59M | Completed | Generating Revenue | |
| 1. Seed Round | 26-Jan-2018 | $1.04M | $1.04M | Completed | Generating Revenue |
Mimikai Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-3 | ||||||||
| Seed-3S | ||||||||
| Seed-2 | 155,445 | $0.001000 | $0.39 | $4.91 | $4.91 | 1x | $4.91 | 6.32% |
| Seed | 323,516 | $0.001000 | $4.25 | $4.25 | 1x | $4.25 | 13.16% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Mimikai Patents
Mimikai Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11627739-B2 | Insect and tick repellent formulations and methods of use thereof | Active | 28-Dec-2017 | ||
| US-12133527-B2 | Insect and tick repellent formulations and methods of use thereof | Active | 28-Dec-2017 | ||
| US-20210037821-A1 | Insect and tick repellent formulations and methods of use thereof | Active | 28-Dec-2017 | ||
| US-20230157278-A1 | Insect and tick repellent formulations and methods of use thereof | Active | 28-Dec-2017 | ||
| WO-2019133675-A1 | Insect and tick repellent formulations and methods of use thereof | Inactive | 28-Dec-2017 | A01N35/02 |
Mimikai Signals
Mimikai Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alpen Capital (Investor) | Family Office | Minority | ||
| Chai Ventures NYC | Venture Capital | Minority | ||
| NewBound Venture Capital | Venture Capital | Minority | ||
| The Venture Collective | Venture Capital | Minority | ||
| Tonic Ventures | Venture Capital | Minority |
Mimikai FAQs
-
When was Mimikai founded?
Mimikai was founded in 2015.
-
Where is Mimikai headquartered?
Mimikai is headquartered in Portland, OR.
-
What is the size of Mimikai?
Mimikai has 8 total employees.
-
What industry is Mimikai in?
Mimikai’s primary industry is Agricultural Chemicals.
-
Is Mimikai a private or public company?
Mimikai is a Private company.
-
What is the current valuation of Mimikai?
The current valuation of Mimikai is .
-
What is Mimikai’s current revenue?
The current revenue for Mimikai is .
-
How much funding has Mimikai raised over time?
Mimikai has raised $5.72M.
-
Who are Mimikai’s investors?
Alpen Capital (Investor), Chai Ventures NYC, NewBound Venture Capital, The Venture Collective, and Tonic Ventures are 5 of 12 investors who have invested in Mimikai.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process